Core Laboratories Inc (CLB) financials
Core Laboratories revenue and earnings by year
Core Laboratories's revenue was $527 million in the fiscal year to December 31, 2025, up 0.5% from the year before. Net income was $29.7 million, 5.6% of revenue. Since the fiscal year to December 31, 2016, revenue has shrunk 1.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 527 | 524 | 510 | 490 | 470 | 487 | 668 | 701 | 648 | 590 |
| Revenue growth | 0.5% | 2.8% | 4.1% | 4.1% | -3.5% | -27.1% | -4.7% | 8.2% | 9.8% | — |
| Gross profit | 109 | 103 | 110 | 96 | 102 | 113 | 173 | 204 | 183 | 153 |
| Gross margin | 20.7% | 19.7% | 21.5% | 19.6% | 21.8% | 23.1% | 25.8% | 29.1% | 28.2% | 25.9% |
| Operating income | 56 | 59 | 55 | 42 | 45 | -77 | 97 | 119 | 110 | 87 |
| Operating margin | 10.7% | 11.2% | 10.7% | 8.5% | 9.6% | -15.8% | 14.5% | 16.9% | 17.0% | 14.8% |
| Net income | 30 | 31 | 37 | 19 | 20 | -98 | 102 | 80 | 83 | 64 |
| Net margin | 5.6% | 6.0% | 7.2% | 4.0% | 4.2% | -20.0% | 15.3% | 11.3% | 12.8% | 10.8% |
| Diluted EPS | $0.63 | $0.66 | $0.77 | $0.42 | $0.44 | -$2.20 | $2.28 | $1.79 | $1.88 | $1.46 |
| Free cash flow | 25 | 45 | 15 | 17 | 23 | 47 | 68 | 90 | 106 | 121 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CLB in Markets.
How Core Laboratories makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Operating Segment Reservoir Description | $84.3M | 63.8% |
| Operating Segment Production Enhancement | $47.8M | 36.2% |
See also: CLB valuation and P/E history · CLB returns
No forecast, no recommendation. This page describes Core Laboratories Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.